Contribution of NK cells to the innate phase of host protection against an intracellular bacterium targeting systemic endothelium.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3388147)

Published in Am J Pathol on May 19, 2012

Authors

Rong Fang1, Nahed Ismail, David H Walker

Author Affiliations

1: Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555-0609, USA.

Articles cited by this

Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol (2002) 3.96

Natural killer cells as an initial defense against pathogens. Curr Opin Immunol (2006) 3.55

An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood (2004) 3.19

Natural killer cells and viral infections. Curr Opin Immunol (2003) 2.63

The role of natural killer cells in innate resistance to infection. Curr Opin Immunol (1993) 2.42

Regulation of hierarchical clustering and activation of innate immune cells by dendritic cells. Immunity (2008) 1.97

A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol (1999) 1.84

NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J Immunol (2006) 1.76

Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J Exp Med (2009) 1.70

Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function. Immunity (2008) 1.65

Depletion of gamma interferon and tumor necrosis factor alpha in mice with Rickettsia conorii-infected endothelium: impairment of rickettsicidal nitric oxide production resulting in fatal, overwhelming rickettsial disease. Infect Immun (1994) 1.62

Adaptive immune responses mediated by natural killer cells. Immunol Rev (2010) 1.48

Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity (2006) 1.44

Rickettsia conorii infection of C3H/HeN mice. A model of endothelial-target rickettsiosis. Lab Invest (1994) 1.41

Relative contributions of NK and CD8 T cells to IFN-gamma mediated innate immune protection against Listeria monocytogenes. J Immunol (2005) 1.39

Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol (2005) 1.39

Mediterranean spotted fever in Portugal: risk factors for fatal outcome in 105 hospitalized patients. Ann N Y Acad Sci (2003) 1.31

Role of natural killer cells in innate resistance to protozoan infections. Curr Opin Immunol (1997) 1.30

Homeostatic regulation of CD8+ T cells by perforin. Eur J Immunol (1999) 1.29

Role of T lymphocyte subsets in immunity to spotted fever group Rickettsiae. J Immunol (1997) 1.24

Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice. Immunity (2003) 1.23

Rickettsia australis infection: a murine model of a highly invasive vasculopathic rickettsiosis. Am J Pathol (1993) 1.23

Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by rickettsiae of the spotted fever group. Am J Pathol (2003) 1.21

Establishment of a novel endothelial target mouse model of a typhus group rickettsiosis: evidence for critical roles for gamma interferon and CD8 T lymphocytes. Lab Invest (2000) 1.17

Natural killer cells and innate immunity to protozoan pathogens. Int J Parasitol (2004) 1.15

Interferon-gamma and tumor necrosis factor-alpha exert their antirickettsial effect via induction of synthesis of nitric oxide. Am J Pathol (1993) 1.10

Mechanisms of immunity against rickettsiae. New perspectives and opportunities offered by unusual intracellular parasites. Microbes Infect (2002) 1.08

The role of cytotoxicity in lymphocyte homeostasis. Curr Opin Immunol (2001) 1.07

The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity. Immunol Cell Biol (2009) 1.06

Rickettsial infection in murine models activates an early anti-rickettsial effect mediated by NK cells and associated with production of gamma interferon. Am J Trop Med Hyg (2001) 1.03

Cross-protection between distantly related spotted fever group rickettsiae. Vaccine (2003) 1.03

Cytosolic localization of Listeria monocytogenes triggers an early IFN-gamma response by CD8+ T cells that correlates with innate resistance to infection. J Immunol (2006) 1.00

The role of host factors in the severity of spotted fever and typhus rickettsioses. Ann N Y Acad Sci (1990) 1.00

Differential interaction of dendritic cells with Rickettsia conorii: impact on host susceptibility to murine spotted fever rickettsiosis. Infect Immun (2007) 0.99

Rocky Mountain spotted fever: a seasonal alert. Clin Infect Dis (1995) 0.99

Vascular permeability and coagulation during Rickettsia rickettsii infection in dogs. Am J Vet Res (1990) 0.94

Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome. Am J Pathol (2010) 0.92

Fulminant Rocky Mountain spotted fever. Its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency. Arch Pathol Lab Med (1983) 0.91

Mediterranean spotted fever with encephalitis. J Med Microbiol (2009) 0.89

Host defenses to Rickettsia rickettsii infection contribute to increased microvascular permeability in human cerebral endothelial cells. J Clin Immunol (2007) 0.85

Demonstration of Rickettsia Conorii-induced coagulative and platelet activation in vivo in patients with Mediterranean spotted fever. Thromb Haemost (1995) 0.84

Rickettsial infections. Ann N Y Acad Sci (2005) 0.83

Fatal Rickettsia conorii subsp. israelensis infection, Israel. Emerg Infect Dis (2008) 0.82

Fatal Mediterranean spotted fever in Greece. Clin Microbiol Infect (2009) 0.82

Articles by these authors

Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med (2011) 13.18

Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature (2005) 7.72

Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. Vector Borne Zoonotic Dis (2011) 3.73

Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep (2006) 3.32

Rickettsia species infecting Amblyomma cooperi ticks from an area in the state of São Paulo, Brazil, where Brazilian spotted fever is endemic. J Clin Microbiol (2004) 2.91

Complete genome sequence of Rickettsia typhi and comparison with sequences of other rickettsiae. J Bacteriol (2004) 2.44

Rickettsia sibirica infection in members of scientific expeditions to northern Asia. Lancet (2003) 2.20

Host- and microbe-related risk factors for and pathophysiology of fatal Rickettsia conorii infection in Portuguese patients. J Infect Dis (2008) 1.97

Emerging and re-emerging rickettsioses: endothelial cell infection and early disease events. Nat Rev Microbiol (2008) 1.92

Directed mutagenesis of the Rickettsia prowazekii pld gene encoding phospholipase D. Infect Immun (2009) 1.83

Rickettsia bellii and Rickettsia amblyommii in Amblyomma ticks from the State of Rondônia, Western Amazon, Brazil. J Med Entomol (2004) 1.77

Unresolved problems related to scrub typhus: a seriously neglected life-threatening disease. Am J Trop Med Hyg (2013) 1.64

Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol (2012) 1.63

Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome. Clin Infect Dis (2013) 1.58

Detection of Rickettsia rickettsii in the tick Amblyomma cajennense in a new Brazilian spotted fever-endemic area in the state of Minas Gerais. Mem Inst Oswaldo Cruz (2006) 1.57

Overproduction of TNF-alpha by CD8+ type 1 cells and down-regulation of IFN-gamma production by CD4+ Th1 cells contribute to toxic shock-like syndrome in an animal model of fatal monocytotropic ehrlichiosis. J Immunol (2004) 1.43

Scrub typhus in previously unrecognized areas of endemicity in China. J Clin Microbiol (2010) 1.41

Cardiac arrest on induction of anesthesia due to triple vessel coronary artery disease despite a "Negative" angiogram. Anesthesiology (2002) 1.40

First serologic evidence of human spotted fever group rickettsiosis in Korea. J Clin Microbiol (2004) 1.38

Emerging pathogens: challenges and successes of molecular diagnostics. J Mol Diagn (2008) 1.38

The developmental cycle of Ehrlichia chaffeensis in vertebrate cells. Cell Microbiol (2006) 1.35

Histologic, serologic, and molecular analysis of persistent ehrlichiosis in a murine model. Am J Pathol (2004) 1.34

Fc-dependent polyclonal antibodies and antibodies to outer membrane proteins A and B, but not to lipopolysaccharide, protect SCID mice against fatal Rickettsia conorii infection. Infect Immun (2004) 1.33

Fatal human infection with Rickettsia rickettsii, Yucatán, Mexico. Emerg Infect Dis (2006) 1.33

An intradermal environment promotes a protective type-1 response against lethal systemic monocytotropic ehrlichial infection. Infect Immun (2006) 1.31

Expression of the Rickettsia prowazekii pld or tlyC gene in Salmonella enterica serovar Typhimurium mediates phagosomal escape. Infect Immun (2005) 1.30

Kinetics of antibody response to Ehrlichia canis immunoreactive proteins. Infect Immun (2003) 1.27

Detection of medically important Ehrlichia by quantitative multicolor TaqMan real-time polymerase chain reaction of the dsb gene. J Mol Diagn (2005) 1.26

Acute spotted fever rickettsiosis among febrile patients, Cameroon. Emerg Infect Dis (2004) 1.25

Pathogenesis of Lassa fever. Viruses (2012) 1.23

Detection of Rickettsia africae in patients and ticks along the coastal region of Cameroon. Am J Trop Med Hyg (2004) 1.21

Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by rickettsiae of the spotted fever group. Am J Pathol (2003) 1.21

Role of tumor necrosis factor alpha (TNF-alpha) and interleukin-10 in the pathogenesis of severe murine monocytotropic ehrlichiosis: increased resistance of TNF receptor p55- and p75-deficient mice to fatal ehrlichial infection. Infect Immun (2006) 1.20

Prevalence of antibodies to spotted fever group rickettsiae in humans and domestic animals in a Brazilian spotted fever-endemic area in the state of São Paulo, Brazil: serologic evidence for infection by Rickettsia rickettsii and another spotted fever group Rickettsia. Am J Trop Med Hyg (2004) 1.19

Rickettsia felis in Ctenocephalides spp. fleas, Brazil. Emerg Infect Dis (2002) 1.19

Detection of Rickettsia felis in a New World flea species, Anomiopsyllus nudata (Siphonaptera: Ctenophthalmidae). J Med Entomol (2005) 1.18

The presence of eschars, but not greater severity, in Portuguese patients infected with Israeli spotted fever. Ann N Y Acad Sci (2005) 1.18

Aponomma hydrosauri, the reptile-associated tick reservoir of Rickettsia honei on Flinders Island, Australia. Am J Trop Med Hyg (2003) 1.18

Molecular evidence for a spotted fever group Rickettsia species in the tick Amblyomma longirostre in Brazil. J Med Entomol (2004) 1.16

Mechanisms of immunity to Ehrlichia muris: a model of monocytotropic ehrlichiosis. Infect Immun (2004) 1.15

Identification and functional analysis of an immunoreactive DsbA-like thio-disulfide oxidoreductase of Ehrlichia spp. Infect Immun (2002) 1.14

The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever. J Virol (2013) 1.13

A mutation inactivating the methyltransferase gene in avirulent Madrid E strain of Rickettsia prowazekii reverted to wild type in the virulent revertant strain Evir. Vaccine (2005) 1.13

Novel Immunoreactive glycoprotein orthologs of Ehrlichia spp. Ann N Y Acad Sci (2003) 1.12

Antigenic variation of Ehrlichia chaffeensis resulting from differential expression of the 28-kilodalton protein gene family. Infect Immun (2002) 1.10

The absence of Toll-like receptor 4 signaling in C3H/HeJ mice predisposes them to overwhelming rickettsial infection and decreased protective Th1 responses. Infect Immun (2008) 1.10

New insight into immunity and immunopathology of Rickettsial diseases. Clin Dev Immunol (2011) 1.10

Current status of immune mechanisms of killing of intracellular microorganisms. FEMS Microbiol Lett (2002) 1.09

Effect of antibody on the rickettsia-host cell interaction. Infect Immun (2004) 1.08

Human ehrlichioses. Med Clin North Am (2002) 1.08

Detection of a typhus group Rickettsia in Amblyomma ticks in the state of Nuevo Leon, Mexico. Ann N Y Acad Sci (2005) 1.08

Mechanisms of immunity against rickettsiae. New perspectives and opportunities offered by unusual intracellular parasites. Microbes Infect (2002) 1.08

Rickettsia hoogstraalii sp. nov., isolated from hard- and soft-bodied ticks. Int J Syst Evol Microbiol (2009) 1.08

Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol (2003) 1.07

Rickettsiosis of the genus Rickettsia in South America. Ann N Y Acad Sci (2003) 1.06

Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis (2003) 1.05

Cross-protection between distantly related spotted fever group rickettsiae. Vaccine (2003) 1.03

Rocky Mountain spotted fever--changing ecology and persisting virulence. N Engl J Med (2005) 1.01

Ehrlichia chaffeensis: a prevalent, life-threatening, emerging pathogen. Trans Am Clin Climatol Assoc (2004) 1.01

Intralesional expression of mRNA of interferon- gamma , tumor necrosis factor- alpha , interleukin-10, nitric oxide synthase, indoleamine-2,3-dioxygenase, and RANTES is a major immune effector in Mediterranean spotted fever rickettsiosis. J Infect Dis (2007) 1.01

Fatal spotted fever rickettsiosis, Minas Gerais, Brazil. Emerg Infect Dis (2003) 1.00

Lymphangitis in a Portuguese patient infected with Rickettsia sibirica. Emerg Infect Dis (2008) 1.00

Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies. Expert Rev Mol Med (2011) 1.00

Differential interaction of dendritic cells with Rickettsia conorii: impact on host susceptibility to murine spotted fever rickettsiosis. Infect Immun (2007) 0.99

Transcription of the Rickettsia felis ompA gene in naturally infected fleas. Am J Trop Med Hyg (2005) 0.99

The endothelium as a target for infections. Annu Rev Pathol (2006) 0.98

Relative importance of T-cell subsets in monocytotropic ehrlichiosis: a novel effector mechanism involved in Ehrlichia-induced immunopathology in murine ehrlichiosis. Infect Immun (2007) 0.97

Ehrlichia species in Rhipicephalus sanguineus ticks in Cameroon. Vector Borne Zoonotic Dis (2007) 0.96

Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses. Proc Natl Acad Sci U S A (2013) 0.95

Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge. Infect Immun (2008) 0.95

Rickettsia felis, the agent of an emerging infectious disease: Report of a new case in Mexico. Arch Med Res (2006) 0.95

Identification of CD8 T-lymphocyte epitopes in OmpB of Rickettsia conorii. Infect Immun (2003) 0.94

Approaches to vaccines against Orientia tsutsugamushi. Front Cell Infect Microbiol (2013) 0.94

Restriction and expansion of Ehrlichia strain diversity. Vet Parasitol (2006) 0.93

Persistent infection contributes to heterologous protective immunity against fatal ehrlichiosis. Infect Immun (2009) 0.93

Rickettsiae stimulate dendritic cells through toll-like receptor 4, leading to enhanced NK cell activation in vivo. J Infect Dis (2009) 0.93

Prospective comparison of R-mix shell vial system with direct antigen tests and conventional cell culture for respiratory virus detection. J Clin Virol (2007) 0.92

Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome. Am J Pathol (2010) 0.92

Exit mechanisms of the intracellular bacterium Ehrlichia. PLoS One (2010) 0.92

Rickettsiae-stimulated dendritic cells mediate protection against lethal rickettsial challenge in an animal model of spotted fever rickettsiosis. J Infect Dis (2007) 0.90

Predominance of Ehrlichia chaffeensis in Rhipicephalus sanguineus ticks from kennel-confined dogs in Limbe, Cameroon. Exp Appl Acarol (2009) 0.90

Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced toxic shock. Infect Immun (2013) 0.90

Prevalence of antibodies against spotted fever group rickettsiae in a rural area of Colombia. Am J Trop Med Hyg (2007) 0.89

A preliminary investigation of Ehrlichia species in ticks, humans, dogs, and capybaras from Brazil. Vet Parasitol (2006) 0.89

Rickettsia in synanthropic and domestic animals and their hosts from two areas of low endemicity for Brazilian spotted fever in the eastern region of Minas Gerais, Brazil. Am J Trop Med Hyg (2010) 0.89

Recent molecular insights into rickettsial pathogenesis and immunity. Future Microbiol (2013) 0.88

Toward gene therapy of endometriosis: adenovirus-mediated delivery of dominant negative estrogen receptor genes inhibits cell proliferation, reduces cytokine production, and induces apoptosis of endometriotic cells. Fertil Steril (2007) 0.88

Human ehrlichioses in Brazil: first suspect cases. Braz J Infect Dis (2004) 0.88

CD4+ CD25+ Foxp3- T-regulatory cells produce both gamma interferon and interleukin-10 during acute severe murine spotted fever rickettsiosis. Infect Immun (2009) 0.88

[Emerging and reemerging rickettsiosis in an endemic area of Minas Gerais State, Brazil]. Cad Saude Publica (2002) 0.87

Infection of the endothelium by members of the order Rickettsiales. Thromb Haemost (2009) 0.87

The interaction between IL-18 and IL-18 receptor limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteria. J Immunol (2011) 0.87